Boehringer Ingelheim gets an injunction against sale of Empagliflozin

Boehringer Ingelheim, a MNC firm has obtained two separate interim injunctions against Dr Reddy’s and MSN Labs for selling their versions of Empagliflozin, an anti-diabetes drug in India. Both these pharma companies have recently launched a low-priced version of the anti-diabetes drug,...